Detection of aminophenylnorharman, a possible endogenous mutagenic and carcinogenic compound, in human urine samples

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 1, 2007, Pages 151-156

  Nishigaki, Rena ^a   Totsuka, Yukari ^a   Kataoka, Hiroyuki ^c   Ushiyama, Hirohumi ^d   Goto, Sumio ^e   Akasu, Takayuki ^b   Watanabe, Tetsushi ^f   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c SHUJITSU UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^e NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^f KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENYLNORHARMAN; ANILINE DERIVATIVE; BETA CARBOLINE DERIVATIVE; CARCINOGEN; MUTAGENIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PATIENT; HUMAN; MALE; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; URINALYSIS;

ADULT; ANILINE COMPOUNDS; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HARMINE; HUMANS; INDOLES; JAPAN; MALE; MIDDLE AGED; MUTAGENS; PYRIDINES; SMOKING;

EID: 33846631530     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0052     Document Type: Article

References (28)

1. Totsuka Y, Ushiyama H, Ishihara J, et al. Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods. Cancer Lett 1999;143:139-43.
2. Nagao M, Yahagi T, Honda M, Seino Y, Matsushima T, Sugimura T. Demonstration of mutagenicity of aniline and o-toluidine by norharman. Proc Jpn Acad 1977;53B:34-7.
3. Nagao M, Yahagi T, Sugimura T. Differences in effects of norharman with various classes of chemical mutagens and amounts of S-9. Biochem Biophys Res Commun 1978;83:373-8.
4. Sugimura T, Nagao M, Wakabayashi K. Metabolic aspects of comutagenic action of norharman, In: Snyder R, Jollow DJ, Parke DV, Gibson CG, Kocsis JJ, Witmer CM, editors. Biological reactive intermediates-II. Chemical mechanisms and biological effects: Part B. New York: Plenum Press; 1982. p. 1011-25.
5. Totsuka Y, Hada N, Matsumoto K, et al. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline. Carcinogenesis 1998;19:1995-2000.
6. Sugimura T. A new concept of co-mutagenicity from a phenomenon forgotten for the past two decades: is it more important than previously expected? Environ Health Perspect 1998;106:A522-3.
7. Nishigaki R, Totsuka Y, Takamura-Enya T, Sugimura T, Wakabayashi K. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline. Mutat Res 2004;562:19-25.
8. Totsuka Y, Takamura-Enya T, Kawahara N, Nishigaki R, Sugimura T, Wakabayashi K. Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline. Chem Res Toxicol 2002;15:1288-94.
9. Wakabayashi K, Nagao M, Esumi H, Sugimura T. Food-derived mutagens and carcinogens. Cancer Res 1992;52:2092-8s.
10. Kawamori T, Totsuka Y, Uchiya N, et al. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats. Carcinogenesis 2004;25:1967-72.
11. Totsuka Y, Kataoka H, Takamura-Enya T, Sugimura T, Wakabayashi K. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline. Mutat Res 2002;506-507:49-54.
12. Ushiyama H, Oguri A, Totsuka Y, Itoh H, Sugimura T, Wakabayashi K. Norharman and harman in human urine. Proc Jpn Acad 1995;71B:57-60.
13. Ushiyama H, Wakabayashi K, Hirose M, Itoh H, Sugimura T, Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis 1991;12:1417-22.
14. IARC. Aniline and Aniline Hydrochloride. IARC monographs on the evaluation of carcinogenic risks of chemicals to humans. Lyon: IARC; 1982. p. 39-61.
15. Riffelmann M, Muller G, Schmieding W, Popp W, Norpoth K. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int Arch Occup Environ Health 1995;68:36-43.
16. DeBruin LS, Pawliszyn JB, Josephy PD. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxicol 1999;12:78-82.
17. Luceri F, Pieraccini G, Moneti G, Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health 1993;9:405-13.
18. Sugimura T, Kawachi T, Nagao M, et al. Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc Jpn Acad 1997;53:58-61.
19. Fekkes D, Tuiten A, Bom I, Pepplinkhuizen L. Tryptophan: a precursor for the endogenous synthesis of norharman in man. Neurosci Lett 2001;303:145-8.
20. Walters DG, Young PJ, Agus C, et al. Cruciferous vegetable consumption alters the metabolism of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) in humans. Carcinogenesis 2004;25:1659-69.
21. Xie W, Yeuh MF, Radominska-Pandya A, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane × receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A 2003;100:4150-5.
22. Li YQ, Prentice DA, Howard ML, Mashford ML, Desmond PV. The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes. Pharm Res 1999;16:191-7.
23. Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005;28:249-68.
24. Nagata K, Yamazoe Y. Genetic polymorphism of human cytochrome p450 involved in drug metabolism. Drug Metab Pharmacokinet 2002;17:167-89.
25. Hada N, Totsuka Y, Enya T, et al. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers. Mutat Res 2001;493:115-26.
26. Totsuka Y, Takamura-Enya T, Nishigaki R, Sugimura T, Wakabayashi K. Mutagens formed from beta-carbolines with aromatic amines. J Chromatogr B 2004;802:135-41.
27. IARC. Ortho-toluidine and Ortho-toluidine hydrochloride. IARC monographs on the evaluation of carcinogenic risks of chemicals to humans. Lyon: IARC; 1982. p. 155-75.
28. Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004;95:290-9.